Burkholderia cepacia complex in cystic fibrosis and non-cystic fibrosis patients: Identification of a cluster of epidemic lineages

Journal of Hospital Infection

Volumn 50, Issue 3, 2002, Pages 188-195

  Agodi, A ^a   Barchitta, M ^a   Giannino V ^a   Collura, A ^b   Pensabene, T ^b   Garlaschi, M L ^c   Pasquarella, C ^d   Luzzaro, F ^e   Sinatra, F ^a   Mahenthiralingam, E ^f   Stefani, S ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b Ospedale dei Bambini G Di Cristina   (Italy)

^c PARKINSON INSTITUTE   (Italy)

^d Department of Hygiene of Perugia ^*  (Italy)

^e OSPEDALE DI CIRCOLO   (Italy)

^f CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Burkholderia cepacia; Cystic fibrosis; Epidemiology; Nosocomial infections

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; AZITHROMYCIN; CEFTAZIDIME; CIPROFLOXACIN; ERYTHROMYCIN; GENTAMICIN; PIPERACILLIN PLUS TAZOBACTAM; TOBRAMYCIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIUM CULTURE; BACTERIUM ISOLATE; BLOOD ANALYSIS; BURKHOLDERIA CEPACIA; CELL LINEAGE; CLONAL VARIATION; CLUSTER ANALYSIS; CONTROLLED STUDY; CYSTIC FIBROSIS; ELECTRON MICROSCOPY; EPIDEMIC; GENETIC EPIDEMIOLOGY; GENETIC IDENTIFICATION; GENETIC SIMILARITY; GENETIC VARIABILITY; HEALTH CENTER; HUMAN; INFECTION CONTROL; INTRAVENOUS CATHETER; ITALY; MAJOR CLINICAL STUDY; NONHUMAN; RESPIRATORY TRACT INFECTION; SURGICAL WOUND; BACTERIAL INFECTION; CROSS INFECTION; DRUG EFFECT; GENETICS; MICROBIOLOGICAL EXAMINATION; OPPORTUNISTIC INFECTION; PULSED FIELD GEL ELECTROPHORESIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ANTI-BACTERIAL AGENTS; BURKHOLDERIA CEPACIA; BURKHOLDERIA INFECTIONS; CROSS INFECTION; CYSTIC FIBROSIS; ELECTROPHORESIS, GEL, PULSED-FIELD; HUMANS; INFECTION CONTROL; MICROBIAL SENSITIVITY TESTS; OPPORTUNISTIC INFECTIONS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH;

EID: 0036512887     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhin.2001.1160     Document Type: Article

References (34)

1. National Nosocomial Infections Surveillance System Report, Data Summary from January 1990-May 1999 Am J Infect Control 27 1999 520-532
2. Van Laer F Raes D Vandamme P et al. An outbreak of Burkholderia cepacia with septicemia on a cardiology ward Infect Control Hosp Epidemiol 19 1998 112-113
3. Yu WL Wang DY Lin CW Tsou MF Endemic Burkholderia cepacia bacteraemia: clinical features and antimicrobial susceptibilities of isolates Scand J Infect Dis 31 1999 293-298
4. Kaitwatcharachai C Silpapojakul K Jtsurong S Kalnauwakul S An outbreak of Burkholderia cepacia bacteremia in hemodialysis patients: an epidemiologic and molecular study Am J Kidney Dis 36 2000 199-204
5. Weems Jr. JJ Nosocomial outbreak of Pseudomonas cepacia associated with contamination of reusable electronic ventilator temperature probes Infect Control Hosp Epidemiol 14 1993 583-586
6. Pegues CF Pegues DA Ford DS et al. Burkholderia cepacia respiratory tract acquisition: epidemiology and molecular characterization of a large nosocomial outbreak Epidemiology Infect 116 1996 309-317
7. Reboli AC Koshinski R Arias K Marks-Austin K Stieritz D Stull TL An outbreak of Burkholderia cepacia lower respiratory tract infection associated with contaminated albuterol nebulization solution Infect Control Hosp Epidemiol 17 1996 741-743
8. MMWR Nosocomial Burkholderia cepacia infection and colonization associated with intrinsically contaminated mouthwash - Arizona 1998 MMWR Morb Mortal Wkly Rep 47 1998 926-928
9. Gillis MTV Van Bardin R Goor M et al. Polyphasic taxonomy in the genus Burkholderia leading to an emended description of the genus and proposition of Burkholderia vietnamiensis sp. nov. for N2-fixing isolates from rice in Vietnam Int J Syst Bacteriol 45 1995 274-289
10. Vandamme P Mahenthiralingam E Holmes B et al. Identification and population structure of Burkholderia stabilis sp. nov. (formerly Burkholderia cepacia genomovar IV) J Clin Microbiol 38 2000 1042-1047
11. Coenye T Mahenthiralingam E Henry D et al. Burkholderia ambifaria sp.nov., a novel member of the Burkholderia cepacia complex comprising biocontrol and cystic-fibrosis related isolates Int J Syst Evol Microbiol 51 2000 1481-1490
12. Goldstein R Sun L Jiang R Sajjan U Forstner J Campanelli C Structurally variant classes of pilus appendage fibers coexpressed from Burkholderia (Pseudomonas) cepacia. J Bacteriol 177 1995 1039-1052
13. Vandamme P Pot B Gillis M de Vos P Kersters K Swings J Polyphasic taxonomy, a consensus approach to bacterial systematics Microbiol Rev 60 1996 407-438
14. Vandamme P Holmes B Vancanneyet M et al. Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov Int J Syst Bacteriol 47 1997 1188-1200
15. Bauernfeind A Schneider I Jungwirth R Roller C Discrimination of Burkholderia multivorans and Burkholderia vietnamiensis from Burkholderia cepacia genomovars I, III, and V by PCR J Clin Microbiol 37 1999 1335-1339
16. LiPuma JJ Burkholderia cepacia. Management issues and new insights Clin Chest Med 19 1998 473-486
17. LiPuma JJ Dulaney BJ McMenamin JD Development of rRNA-based PCR assays for identification of Burkholderia cepacia complex isolates recovered from cystic fibrosis patients J Clin Microbiol 37 2000 3167-3170
18. Segonds C Heulin T Marty N Chabanon G Differentiation of Burkholderia species by PCR-restriction fragment length polymorphism analysis of 16S rRNA gene and application to cystic fibrosis isolates J Clin Microbiol 37 1999 2201-2208
19. Mahenthiralingam E Bischof J Byrne SK et al. DNA-based diagnostic approaches for identification of Burkholderia cepacia complex, Burkholderia vietnamiensis, Burkholderia multivorans, Burkholderia stabilis, and Burkholderia cepacia genomovars I and II J Clin Microbiol 38 2000 3165-3173
20. Holmes A Nolan R Taylor R et al. An epidemic of Burkholderia cepacia transmitted between patients with and without Cystic Fibrosis J Inf Dis 179 1999 1197-1205
21. Agodi A Mahenthiralingam E Barchitta M Gianninò V Sciacca A Stefani S Burkholderia cepacia complex infection in Italian patients with cystic fibrosis: prevalence, epidemiology and genomovar status J Clin Microbiol 39 2001 2891-2896
22. Johnson W Tyler S Rozee K Linkage analysis of geographic and clinical clusters in Pseudomonas cepacia infections by multilocus enzyme electrophoresis and ribotyping J Clin Microbiol 32 1994 924-930
23. Mahenthiralingam E Simpson D Speert DP Identification and characterization of a novel DNA marker associated with epidemic Burkholderia cepacia strains recovered from patients with cystic fibrosis J Clin Microbiol 35 1997 808-816
24. Pitt TL Kaufmann ME Patel PS Benge LCA Gaskin S Livermore DM Type characterization and antibiotic susceptibility Burkholderia (Pseudomonas) cepacia isolates from patients with cystic fibrosis in the United Kingdom and the Republic of Ireland J Med Microbiol 44 1996 203-210
25. Sun L Jiang R Steinbach S et al. The emergence of highly transmissible lineage of cbl+ Pseudomonas (Burkholderia) cepacia cause CF centre epidemics in North America and Britain Nature Med 1 1995 661-666
26. Grothues D Koopmann U Van der Hardt H Tummler B Genome fingerprinting of Pseudomonas aeruginosa indicates colonization of cystic fibrosis siblings with closely related strains J Clin Microbiol 26 1988 115-123
27. National Committee for Clinical Laboratory Standard. Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard. Seventh Edition M02-A7.
28. Struelens M Consensus guidelines for appropriate use and evaluation of microbial epidemiologic typing systems Clin Microbiol Inf 2 1996 2-11
29. Tenover F Arbeit R Goering R Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing J Clin Microbiol 33 1995 2333-2339
30. Agodi A Campanile F Basile G Viglianisi F Stefani S Phylogenetic analysis of macrorestriction fragments as a measure of genetic relatedness in Staphylococcus aureus: the epidemiological impact of methicillin resistance Eur J Epidemiol 15 1999 637-642
31. Nei M Lei WH Mathematical model for studyng genetic variation in terms of restriction endonucleases Proc Natl Acad Sci 76 1979 5269-5273
32. Kruskal J Multidimensional scaling by optimising goodness of fit to a nonmetric hypothesis Psycometrika 29 1964 1-27
33. Govan JRW Hughes J Vandamme P Burkholderia cepacia: medical, taxonomic and ecological issues J Med Microbiol 45 1996 395-397
34. Coenye T Scholuls LM Govan JRW Kesters K Vandamme P Identification of Burkholderia species and genomovars from cystic fibrosis patients by AFLP fingerprinting Int J Syst Bacteriol 49 1999 1657-1666